Elsevier Partners with the Chinese Chemical Society
Amsterdam, 7 August 2006 – Elsevier is pleased to announce a recently-signed partnership with the Chinese Chemical Society (CCS) to publish Chinese Chemical Letters.
Chinese Chemical Letters is an English-language publication and will be included in the China Collection on Elsevier’s ScienceDirect electronic full-text journal platform. In June 2005, Elsevier launched its comprehensive Chinese Journal Cooperation Program (CJCP) partnering with Chinese publishers, societies and research institutes, to improve international quality and distribution of Chinese journals. The ScienceDirect China Collection is a series of prestigious Chinese science, technology and medical journals never before disseminated outside of China.
Elsevier publisher Gilles Jonker commented that “this exciting partnership enhances our well-established chemistry portfolio and has been the result of close collaboration with colleagues in our Beijing office and with representatives of the Chinese Chemical Society, to achieve our shared goal to extend the global reach and visibility of Chinese Chemical Letters”.
Fang Zhi, Vice Secretary General of the Chinese Chemical Society added, “For many years, we have strived towards making Chinese Chemical Letters into the strong scientific journal it is today. Yet it has always been a challenge to reach a large international audience. Through the cooperation with Elsevier, our journal will now appear on ScienceDirect, which is the world’s largest scientific database, and has many millions of users. We trust that our quality journal in combination with Elsevier’s worldwide presence, will lead to a highly beneficial cooperation for both parties”.
# # #
About the Chinese Chemical Society
The Chinese Chemical Society is an academic organization formed by Chinese chemists and aims at uniting Chinese chemists at home and abroad to promote the development of chemistry in China.
Elsevier is committed to building unique, long-lasting relationships to help societies achieve their publishing goals and provide value-added member services. Elsevier partners with more than 500 international learned societies, professional associations and research institutes.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Phone (31) 20 485 3836